CO2激光蒸发在局部晚期黑色素瘤中的应用。

IF 1 Q4 ONCOLOGY
Melanoma Management Pub Date : 2019-04-18 eCollection Date: 2019-03-01 DOI:10.2217/mmt-2018-0008
Otis M Vrielink, Schelto Kruijff, Barbara L van Leeuwen, Jan Ln Roodenburg
{"title":"CO2激光蒸发在局部晚期黑色素瘤中的应用。","authors":"Otis M Vrielink,&nbsp;Schelto Kruijff,&nbsp;Barbara L van Leeuwen,&nbsp;Jan Ln Roodenburg","doi":"10.2217/mmt-2018-0008","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>This study aims to investigate the role of CO<sub>2</sub> laser evaporation in the treatment of melanoma patients with satellite or in-transit metastases.</p><p><strong>Materials & methods: </strong>Patients who underwent CO<sub>2</sub> laser evaporation were retrospectively included between November 2002 and August 2018. The Sharplan 40C CO<sub>2</sub> laser was used with a high pulse wave mode. Data concerning patient and tumor characteristics, CO<sub>2</sub> laser evaporation and subsequent therapies were collected.</p><p><strong>Results: </strong>A total of 26 patients were included. Median duration of local control was 5.5 months. The median number of lesions evaporated per treatment was three (1-16); patients received a median of three (1-19) treatments.</p><p><strong>Conclusion: </strong>In a selected group of melanoma patients with satellite or in-transit metastases, CO<sub>2</sub> laser evaporation should be considered as treatment for local control.</p>","PeriodicalId":44562,"journal":{"name":"Melanoma Management","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2019-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/mmt-2018-0008","citationCount":"1","resultStr":"{\"title\":\"Application of CO<sub>2</sub> laser evaporation in locally advanced melanoma.\",\"authors\":\"Otis M Vrielink,&nbsp;Schelto Kruijff,&nbsp;Barbara L van Leeuwen,&nbsp;Jan Ln Roodenburg\",\"doi\":\"10.2217/mmt-2018-0008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aim: </strong>This study aims to investigate the role of CO<sub>2</sub> laser evaporation in the treatment of melanoma patients with satellite or in-transit metastases.</p><p><strong>Materials & methods: </strong>Patients who underwent CO<sub>2</sub> laser evaporation were retrospectively included between November 2002 and August 2018. The Sharplan 40C CO<sub>2</sub> laser was used with a high pulse wave mode. Data concerning patient and tumor characteristics, CO<sub>2</sub> laser evaporation and subsequent therapies were collected.</p><p><strong>Results: </strong>A total of 26 patients were included. Median duration of local control was 5.5 months. The median number of lesions evaporated per treatment was three (1-16); patients received a median of three (1-19) treatments.</p><p><strong>Conclusion: </strong>In a selected group of melanoma patients with satellite or in-transit metastases, CO<sub>2</sub> laser evaporation should be considered as treatment for local control.</p>\",\"PeriodicalId\":44562,\"journal\":{\"name\":\"Melanoma Management\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2019-04-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.2217/mmt-2018-0008\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Melanoma Management\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2217/mmt-2018-0008\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2019/3/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Melanoma Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2217/mmt-2018-0008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/3/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 1

摘要

目的:本研究旨在探讨CO2激光蒸发在黑色素瘤伴卫星或中转转移患者治疗中的作用。材料与方法:回顾性纳入2002年11月至2018年8月期间接受CO2激光蒸发治疗的患者。Sharplan 40C CO2激光器采用高脉冲波模式。收集患者及肿瘤特征、CO2激光蒸发及后续治疗等资料。结果:共纳入26例患者。局部控制的中位持续时间为5.5个月。每次治疗中消失的病灶数为3 (1-16);患者平均接受3次(1-19次)治疗。结论:在一组有卫星或传输转移的黑色素瘤患者中,CO2激光蒸发治疗可作为局部控制的治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Application of CO<sub>2</sub> laser evaporation in locally advanced melanoma.

Application of CO<sub>2</sub> laser evaporation in locally advanced melanoma.

Application of CO<sub>2</sub> laser evaporation in locally advanced melanoma.

Application of CO2 laser evaporation in locally advanced melanoma.

Aim: This study aims to investigate the role of CO2 laser evaporation in the treatment of melanoma patients with satellite or in-transit metastases.

Materials & methods: Patients who underwent CO2 laser evaporation were retrospectively included between November 2002 and August 2018. The Sharplan 40C CO2 laser was used with a high pulse wave mode. Data concerning patient and tumor characteristics, CO2 laser evaporation and subsequent therapies were collected.

Results: A total of 26 patients were included. Median duration of local control was 5.5 months. The median number of lesions evaporated per treatment was three (1-16); patients received a median of three (1-19) treatments.

Conclusion: In a selected group of melanoma patients with satellite or in-transit metastases, CO2 laser evaporation should be considered as treatment for local control.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.10
自引率
0.00%
发文量
4
审稿时长
13 weeks
期刊介绍: Skin cancer is on the rise. According to the World Health Organization, 132,000 melanoma skin cancers occur globally each year. While early-stage melanoma is usually relatively easy to treat, once disease spreads prognosis worsens considerably. Therefore, research into combating advanced-stage melanoma is a high priority. New and emerging therapies, such as monoclonal antibodies, B-RAF and KIT inhibitors, antiangiogenic agents and novel chemotherapy approaches hold promise for prolonging survival, but the search for a cure is ongoing. Melanoma Management publishes high-quality peer-reviewed articles on all aspects of melanoma, from prevention to diagnosis and from treatment of early-stage disease to late-stage melanoma and metastasis. The journal presents the latest research findings in melanoma research and treatment, together with authoritative reviews, cutting-edge editorials and perspectives that highlight hot topics and controversy in the field. Independent drug evaluations assess newly approved medications and their role in clinical practice. Key topics covered include: Risk factors, prevention and sun safety education Diagnosis, staging and grading Surgical excision of melanoma lesions Sentinel lymph node biopsy Biological therapies, including immunotherapy and vaccination Novel chemotherapy options Treatment of metastasis Prevention of recurrence Patient care and quality of life.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信